BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 21568912)

  • 1. Removing protein aggregates: the role of proteolysis in neurodegeneration.
    Nijholt DA; De Kimpe L; Elfrink HL; Hoozemans JJ; Scheper W
    Curr Med Chem; 2011; 18(16):2459-76. PubMed ID: 21568912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
    Ciechanover A; Kwon YT
    Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein clearance strategies for disease intervention.
    Hommen F; Bilican S; Vilchez D
    J Neural Transm (Vienna); 2022 Feb; 129(2):141-172. PubMed ID: 34689261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ubiquitin-proteasome system in neurodegeneration.
    McKinnon C; Tabrizi SJ
    Antioxid Redox Signal; 2014 Dec; 21(17):2302-21. PubMed ID: 24437518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of ubiquitin proteasome system: risk for neurodegenerative diseases.
    Zheng C; Geetha T; Babu JR
    Neurodegener Dis; 2014; 14(4):161-75. PubMed ID: 25413678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat Shock Proteins and Autophagy Pathways in Neuroprotection: from Molecular Bases to Pharmacological Interventions.
    Penke B; Bogár F; Crul T; Sántha M; Tóth ME; Vígh L
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29361800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteostasis in neurodegenerative diseases.
    Kinger S; Jagtap YA; Kumar P; Choudhary A; Prasad A; Prajapati VK; Kumar A; Mehta G; Mishra A
    Adv Clin Chem; 2024; 121():270-333. PubMed ID: 38797543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein damage, repair and proteolysis.
    Chondrogianni N; Petropoulos I; Grimm S; Georgila K; Catalgol B; Friguet B; Grune T; Gonos ES
    Mol Aspects Med; 2014 Feb; 35():1-71. PubMed ID: 23107776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin proteasome system as a pharmacological target in neurodegeneration.
    Hol EM; Fischer DF; Ovaa H; Scheper W
    Expert Rev Neurother; 2006 Sep; 6(9):1337-47. PubMed ID: 17009921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitin-dependent and independent roles of SUMO in proteostasis.
    Liebelt F; Vertegaal AC
    Am J Physiol Cell Physiol; 2016 Aug; 311(2):C284-96. PubMed ID: 27335169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collective roles of molecular chaperones in protein degradation pathways associated with neurodegenerative diseases.
    Luo GR; Le WD
    Curr Pharm Biotechnol; 2010 Feb; 11(2):180-7. PubMed ID: 20166963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS.
    Pandey UB; Nie Z; Batlevi Y; McCray BA; Ritson GP; Nedelsky NB; Schwartz SL; DiProspero NA; Knight MA; Schuldiner O; Padmanabhan R; Hild M; Berry DL; Garza D; Hubbert CC; Yao TP; Baehrecke EH; Taylor JP
    Nature; 2007 Jun; 447(7146):859-63. PubMed ID: 17568747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Walking the tightrope: proteostasis and neurodegenerative disease.
    Yerbury JJ; Ooi L; Dillin A; Saunders DN; Hatters DM; Beart PM; Cashman NR; Wilson MR; Ecroyd H
    J Neurochem; 2016 May; 137(4):489-505. PubMed ID: 26872075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications.
    Williams A; Jahreiss L; Sarkar S; Saiki S; Menzies FM; Ravikumar B; Rubinsztein DC
    Curr Top Dev Biol; 2006; 76():89-101. PubMed ID: 17118264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Influence of Cyclo(His-Pro) on Proteostasis: Impact on Neurodegenerative Diseases.
    Grottelli S; Costanzi E; Peirce MJ; Minelli A; Cellini B; Bellezza I
    Curr Protein Pept Sci; 2018; 19(8):805-812. PubMed ID: 29708066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications.
    Huang Q; Figueiredo-Pereira ME
    Apoptosis; 2010 Nov; 15(11):1292-311. PubMed ID: 20131003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggregopathy in neurodegenerative diseases: mechanisms and therapeutic implication.
    Dohm CP; Kermer P; Bähr M
    Neurodegener Dis; 2008; 5(6):321-38. PubMed ID: 18309232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease?
    Matsuda N; Tanaka K
    J Alzheimers Dis; 2010; 19(1):1-9. PubMed ID: 20061621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of protein clearance mechanisms in organismal ageing and age-related diseases.
    Vilchez D; Saez I; Dillin A
    Nat Commun; 2014 Dec; 5():5659. PubMed ID: 25482515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The disturbance of protein synthesis/degradation homeostasis is a common trait of age-related neurodegenerative disorders.
    Di Domenico F; Lanzillotta C
    Adv Protein Chem Struct Biol; 2022; 132():49-87. PubMed ID: 36088079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.